Technology · Biochemistry & industrial biotech / Specialty & fine chemicals
Biosynthetic cannabinoids (CBD & THC)
Producing CBD, THC and rare cannabinoids (CBG, CBDV, THCV) as platform molecules via engineered yeast fermentation and chemo-enzymatic synthesis, bypassing plant cultivation.
1 · What it gives
Biosynthetic cannabinoid production replaces field-grown hemp with engineered microbial fermentation or chemo-enzymatic synthesis to manufacture CBD, THC and rarer cannabinoids (CBG, CBDV, THCV) as pharmaceutical-grade platform molecules. In the US, the DEA’s 2024 rescheduling of cannabis from Schedule I to Schedule III removed decades-old research restrictions and accelerated venture investment into precision cannabinoid biology; Jazz Pharmaceuticals’ plant-derived CBD drug Epidiolex reported 15% year-on-year sales growth in Q1 2026 within a company-wide revenue increase of 19%. Engineered-yeast platforms are the fastest-growing production route: Willow Biosciences has engineered a quadruple-mutant prenyltransferase (NphB variant V49W/S214H/A232S/Y288P) for efficient cannabigerolic acid (CBGA) synthesis and signed a multi-product API licensing and manufacturing partnership with Laurus Labs, while Ginkgo Bioworks holds patent filings on recombinant-cell biosynthesis of cannabinoids and their precursors. Purity standards are stringent throughout: DEA-licensed bulk manufacturers such as Purisys operate under Schedule I-V handling permits and GMP/DMF certification to supply pharmaceutical-grade isolates.
The key directions of biosynthetic cannabinoids are:
- Precision fermentation (Precision Fermentation): engineering yeast (commonly Saccharomyces cerevisiae) to express the full cannabinoid biosynthesis pathway — hexanoyl-CoA, olivetolic acid synthase/cyclase, and a prenyltransferase — directly from simple sugars, without cultivating cannabis plants.
- Rare-cannabinoid access (Rare-Cannabinoid Access): producing minor cannabinoids (CBG, CBC, THCV, CBDV) that occur at trace levels in the plant but can be made at scale via selective enzymatic cyclization of the common CBGA precursor.
- Chemo-enzymatic and chemical synthesis (Chemo-Enzymatic Synthesis): acid-catalyzed and enzyme-assisted routes to ultra-high-purity CBD/THC isolates for DEA-licensed bulk manufacturers supplying pharmaceutical formulators.
- Purification engineering (Purification Engineering): supercritical CO2 extraction and centrifugal partition chromatography to separate structurally similar cannabinoids to pharmacopeial purity without residual solvent.
Sectoral value chain#
[Feedstock/Strain] ──> [Synbio & Biosynthesis] ──> [Extraction & Purification] ──> [B2B Distribution]
│
(GMP validation)
│
▼
[End Markets] <─── [Regulatory Certification] <─────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| 1. Feedstock/strain engineering | Selecting low-THC hemp cultivars or engineering a production host (yeast/bacteria) with the cannabinoid pathway. | In: Hemp seed stock or a host microbial strain. Out: Cultivar or engineered production strain. |
| 2. Fermentation/biosynthesis | Expressing the CBGA pathway (olivetolic acid synthase, prenyltransferase) and downstream synthases (THCA/CBDA/CBCA-synthase) in the host. | In: Simple sugars, engineered genetic circuit. Out: Crude cannabinoid-acid broth. |
| 3. Decarboxylation | Mild thermal treatment converting the acidic cannabinoid forms (CBDA/THCA) into their neutral, bioactive forms. | In: Cannabinoid-acid biomass/broth. Out: Neutral cannabinoids (CBD/THC/CBC). |
| 4. Supercritical CO2 extraction | Extracting lipophilic cannabinoids and terpenes with CO2 above its critical point, leaving polar plant matter behind. | In: Decarboxylated biomass, CO2. Out: Crude cannabinoid oil (~50-60% purity). |
| 5. Winterization & chromatography | Cold-ethanol wax removal followed by centrifugal partition chromatography to separate closely related cannabinoids. | In: Crude oil, ethanol. Out: Purified cannabinoid distillate (>99.8% fraction purity). |
| 6. Crystallization & GMP release | Controlled cooling crystallization, HPLC purity testing, and GMP-compliant packaging for pharmaceutical customers. | In: Purified distillate. Out: GMP-certified cannabinoid API (crystalline isolate). |
Cross-cutting technologies of the sector:
- Prenyltransferase engineering: directed evolution of prenyltransferase enzymes (e.g., engineered NphB variants) to efficiently couple geranyl pyrophosphate to olivetolic acid, forming the universal CBGA precursor.
- Supercritical CO2 extraction (SC-CO2): CO2 held above ~73 bar and 31°C behaves as a solvent with gas-like penetration, selectively pulling lipophilic cannabinoids from biomass while leaving chlorophyll and heavy metals behind.
- Centrifugal partition chromatography (CPC): solid-support-free liquid-liquid chromatography that separates structurally close cannabinoids (e.g., minor CBG from bulk CBD) to fraction purities above 99.8%.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Biomass preparation and decarboxylationFormulation & blendingDried hemp biomass (or fermentation-derived cannabinoid-acid biomass) is milled to ~2mm particle size and heated in a vacuum oven at roughly 110°C for about 4 hours, converting acidic CBDA into its neutral, bioactive CBD form.Who can do this step matched automatically✓ ISO 9001 500 m3“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”Alltech United States✓ ISO 9001“Our team produces specialty ingredients, premix supplements, feed and biologicals, backed by science and an unparalleled platform of services.”500,000 tons pilot scale“It refines sugar (including refined white sugar, golden brown sugar, fine granulated sugar and invert sugar syrup), produces bio-based chemicals/biotech outputs (alcohol, …”
- 2Supercritical CO2 extractionExtractionLiquid CO2 above its critical point (roughly 280 bar, 45°C) selectively dissolves lipophilic cannabinoids into a crude resin containing about 50-60% CBD, while leaving behind polar plant matter.Who can do this step matched automatically✓ ISO 9001 228,000 tons“It produces bread/Chinese-staple yeasts, yeast extracts, brewing yeasts, yeast protein and other food ingredients, animal feed additives, and nutrition/health products, leveraging …”“Aum Enzymes is a metabolic engineering firm specializing in generally regarded safe microbial origin Industrial, Food, Feed, Neutraceutical, cosmetic, plant origin [botonical] …”“VTR Biotech is a global science-driven biotechnology company founded in 1991, active in research, development, production, and distribution of advanced enzyme solutions, plant …”ScaleUp Bio Singapore10,000 L pilot scale“Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”
- 3Winterization (wax removal)The crude resin is dissolved in anhydrous ethanol and frozen (around -40°C) for about 24 hours, precipitating plant waxes that are removed by filtration.
- 4Rotary evaporation and solvent recoveryPurification & downstreamThe winterized ethanol solution is distilled under reduced pressure (~100 mbar, 40°C) to recover ethanol for reuse and yield a purified distillate oil.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”Alfa Laval Sweden✓ ISO 9001“Here we compare the three most common options: centrifugation, filtration and coalescence.”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
- 5Crystallization and isolationPurification & downstreamThe distillate is dissolved in warm hexane/pentane and cooled in a controlled manner (roughly 1°C per hour) to precipitate CBD crystals, which are separated by centrifuge and vacuum-dried.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”Alfa Laval Sweden✓ ISO 9001“Here we compare the three most common options: centrifugation, filtration and coalescence.”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
- 6HPLC testing and GMP packagingPackaging & fill-finishDried crystals are milled to a micronized powder (targeting >99.5% CBD purity, <0.01% THC), tested by HPLC/ICP-MS for heavy metals and pesticide residues, then packaged under GMP for pharmaceutical customers.Who can do this step matched automaticallyPakka (ex-Yash Pakka) India1940 MT per annum industrial scale“Pakka Limited (located in Ayodhya, India) provides regenerative packaging solutions for food products.”RWDC Industries Singaporeindustrial scale“2026-04-02 [A Major Step Forward in the Fight Against Microplastics — RWDC Industries is positioning itself as a leader in sustainable biopolymers, specifically Solon PHA, a fully …”
4 · Who delivers
Matched suppliers (matched automatically)
| Ginkgo Bioworks | United States | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| VTR Biotech 溢多利 (SZ 300381) | China | Producer | active |
| UMAMI Bioworks | Singapore | Producer | active |
| Fermelanta | Japan | Producer | active |
| Zero Cow Factory | India | Producer | active |
In the services and supply catalogue 2 · paid service
Contract manufacturing (CMO/CDMO/toll) · Upstream — fermentation & cell culture
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Jazz Pharmaceuticals | 🇮🇪 Ireland | Epidiolex (CBD), Sativex | Plant-derived, FDA/EMA-approved neurotherapeutics | commercial |
| Ginkgo Bioworks | 🇺🇸 USA | Recombinant-cell cannabinoid biosynthesis (patents) | Synthetic-biology foundry model applied to cannabinoid pathways | operating |
| Willow Biosciences | 🇨🇦 Canada | Biosynthetic CBGA/CBG, API licensing with Laurus Labs | Engineered prenyltransferase (NphB quadruple mutant) | operating |
| Purisys | 🇺🇸 USA | High-purity CBD/THC isolates | DEA Schedule I-V license, chemo-enzymatic synthesis, GMP/DMF | commercial |
5 · Rules & route to market
United States
The US leads both plant-derived and biosynthetic cannabinoid commercialization, propelled by the DEA’s 2024 Schedule III reclassification and a wave of venture-funded precision-biology startups.
DEA rescheduling, precision-fermentation startups, DEA-licensed bulk manufacturing#
- Jazz Pharmaceuticals: markets Epidiolex, the FDA-approved plant-derived CBD drug for severe childhood epilepsy, reporting 15% year-on-year sales growth in Q1 2026 as part of 19% overall company revenue growth.
- Ginkgo Bioworks: holds patent filings covering recombinant-cell biosynthesis of cannabinoids and cannabinoid precursors, applying its synthetic-biology foundry model to the sector.
- Purisys: a DEA-licensed (Schedule I-V) bulk manufacturer of ultra-high-purity CBD/THC isolates under FDA Drug Master File and GMP certification, recently acquired by Siegfried, a global pharmaceutical CDMO.
European Union
The EU’s cannabinoid economy centers on pharmaceutical integration and a Novel Food compliance pathway for CBD, rather than domestic biosynthesis capacity.
Novel Food certification, pharmaceutical integration, GMP extraction capacity#
- Novel Food status for CBD: EFSA classifies non-decarboxylated CBD as a Novel Food, requiring a full toxicological dossier before producers can sell it in functional beverages, adaptogenic blends or sports-nutrition products.
- Jazz Pharmaceuticals (Ireland): headquartered in Dublin, Jazz markets Epidiolex across EU markets under EMA approval for severe childhood epilepsy syndromes.
- GMP extraction capacity: German and Polish facilities operate GMP-certified supercritical-CO2 extraction lines, supplying pharmaceutical-grade cannabinoid intermediates to the EU market.
China
China dominates raw industrial-hemp cultivation and export rather than cannabinoid biosynthesis — no dedicated Chinese biosynthetic-cannabinoid producer was confirmed via live sourcing for this article.
industrial hemp cultivation scale, cosmetic/textile export, domestic sales restriction#
- Cultivation scale: China grows a large share of the world’s industrial hemp, concentrated in Yunnan and Heilongjiang provinces, primarily for fiber, seed-oil and cosmetic-extract export rather than domestic CBD sales, which remain tightly restricted.
- Export orientation: hemp-derived CBD extracts produced under state oversight are exported to Asian and EU cosmetics markets rather than sold as pharmaceutical or wellness products domestically.
- NMPA posture: China has not opened an NMPA pathway for cannabinoid pharmaceuticals or wellness products, keeping the domestic market oriented toward fiber and industrial hemp rather than platform-molecule biosynthesis.
6 · Money: tenders & grants
| Grant | Strengthening plant health: addressing emerging plant pest risks European Commission · EU | Apr 8, 2027 174 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 179 days |
7 · Tech stack & innovations
The cannabinoid biosynthesis stack pairs synthetic-biology pathway engineering with pharmaceutical-grade downstream purification.
- Heterologous biosynthesis pathway (yeast):
- Genes for hexanoyl-CoA synthesis, olivetolic acid synthase/cyclase, and a prenyltransferase are assembled in S. cerevisiae to produce cannabigerolic acid (CBGA), the universal precursor, directly from sugar.
- Downstream synthases (THCA-, CBDA-, CBCA-synthase) selectively cyclize CBGA into the target cannabinoid acid, which mild heat then decarboxylates to its neutral, active form.
- Supercritical CO2 extraction:
- Operating in the 250-300 bar range at controlled temperature, SC-CO2 selectively dissolves lipophilic cannabinoids and terpenes while excluding polar chlorophyll, sugars and heavy metals.
- Winterization in cold ethanol then precipitates plant waxes, which are removed by filtration before solvent recovery.
- Centrifugal partition chromatography and crystallization:
- CPC achieves continuous separation of closely related cannabinoids (e.g., minor CBG from bulk CBD) without a solid stationary phase, reaching fraction purities above 99.8%.
- Controlled-rate cooling crystallization (avoiding amorphous precipitation) yields pharmacopeial-grade crystalline isolate, typically specified above 99.5% purity with THC below 0.01%.
Sources 4 · 0 independent · 4 producer sites
Producers' own sites 4
- Ginkgo bioworks producer checked 2026-06-24 · link not kept
- Purisys producer checked 2026-04-03 · link not kept
- Willow biosciences producer checked 2025-06-03 · link not kept
- Jazz pharmaceuticals producer checked 2026-05-05 · link not kept